Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis Xavier

Showing results (41-50 of 152) with videos related to

Pageof 16
Sort By:
European Heart Journal. Quality of Care & Clinical Outcomes|December 28, 2021
The cost implications of a polypill for primary prevention in the TIPS-3 trialAndre Lamy, Wesley Tong, Philip Joseph, et al.
Stroke|April 5, 2012
Treatment with B vitamins and incidence of cancer in patients with previous stroke or transient ischemic attack: results of a randomized placebo-controlled trialGraeme J Hankey, John W Eikelboom, Qilong Yi, et al.
JAMA|January 27, 2005
Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trialShamir R Mehta, Salim Yusuf, Rafael Díaz, et al.
European Heart Journal|November 30, 2013
Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges, Salim Yusuf, Amir Attaran, et al.
The Lancet. Neurology|May 5, 2012
Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trialGraeme J Hankey, John W Eikelboom, Qilong Yi, et al.
European Heart Journal|December 1, 2021
Anger or emotional upset and heavy physical exertion as triggers of stroke: the INTERSTROKE studyAndrew Smyth, Martin O'Donnell, Graeme J Hankey, et al.
The Lancet. Global Health|April 18, 2021
The role and challenges of cluster randomised trials for global healthLouis Dron, Monica Taljaard, Yin Bun Cheung, et al.
American Heart Journal|December 15, 2010
Fondaparinux with UnfracTionated heparin dUring Revascularization in Acute coronary syndromes (FUTURA/OASIS 8): a randomized trial of intravenous unfractionated heparin during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes initially treated with fondaparinuxPhilippe Gabriel Steg, Shamir Mehta, Sanjit Jolly, et al.
JAMA|November 29, 2007
Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarctionRafael Díaz, Abhinav Goyal, Shamir R Mehta, et al.
American Heart Journal|December 16, 2014
Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trialChristopher B Granger, Renato D Lopes, Michael Hanna, et al.
Pageof 16

Showing results (41-50 of 152) with videos related to

Sort By:
Pageof 16
European Heart Journal. Quality of Care & Clinical Outcomes|December 28, 2021
The cost implications of a polypill for primary prevention in the TIPS-3 trialAndre Lamy, Wesley Tong, Philip Joseph, et al.
Stroke|April 5, 2012
Treatment with B vitamins and incidence of cancer in patients with previous stroke or transient ischemic attack: results of a randomized placebo-controlled trialGraeme J Hankey, John W Eikelboom, Qilong Yi, et al.
JAMA|January 27, 2005
Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trialShamir R Mehta, Salim Yusuf, Rafael Díaz, et al.
European Heart Journal|November 30, 2013
Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges, Salim Yusuf, Amir Attaran, et al.
The Lancet. Neurology|May 5, 2012
Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trialGraeme J Hankey, John W Eikelboom, Qilong Yi, et al.
European Heart Journal|December 1, 2021
Anger or emotional upset and heavy physical exertion as triggers of stroke: the INTERSTROKE studyAndrew Smyth, Martin O'Donnell, Graeme J Hankey, et al.
The Lancet. Global Health|April 18, 2021
The role and challenges of cluster randomised trials for global healthLouis Dron, Monica Taljaard, Yin Bun Cheung, et al.
American Heart Journal|December 15, 2010
Fondaparinux with UnfracTionated heparin dUring Revascularization in Acute coronary syndromes (FUTURA/OASIS 8): a randomized trial of intravenous unfractionated heparin during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes initially treated with fondaparinuxPhilippe Gabriel Steg, Shamir Mehta, Sanjit Jolly, et al.
JAMA|November 29, 2007
Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarctionRafael Díaz, Abhinav Goyal, Shamir R Mehta, et al.
American Heart Journal|December 16, 2014
Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trialChristopher B Granger, Renato D Lopes, Michael Hanna, et al.
Pageof 16